Apr. 6, 2022—Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.
Feb. 10, 2022—In 2015 a team at Vanderbilt launched the Research Electronic Data Capture (REDCap) Mobile Application. As of a year ago, the app had been enabled by 802 organizations around the world and had been used for 9,871 projects involving 19,636 end-users.
Jan. 31, 2022—The second virtual REDCap Day event, which will be held via Zoom on Feb. 16-18. The event will be held from 8 a.m.- noon CST on Feb. 16, and 8-11a.m. CST on Feb. 17 and 18. You may attend as many or as few sessions as your schedule allows. All VU, VUMC and Meharry REDCap...
Apr. 29, 2021—Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.
Mar. 3, 2021—Each year at VUMC, REDCap Day brings together local users from VUMC, Vanderbilt University and Meharry Medical College for a morning of brief presentations on innovative use cases and new and upcoming features.
Feb. 11, 2021—The arrival last March of the COVID-19 pandemic in Tennessee presented challenges for the clinical research enterprise at Vanderbilt University Medical Center. Prompt recruitment of patients newly diagnosed with COVID-19 into clinical trials was, and remains, a public health imperative with top-level backing from the federal government.
Sep. 24, 2020—Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.
Jun. 9, 2020—REDCap, the research data management tool created and powered by Vanderbilt University Medical Center, is serving extra duty as research teams and public health authorities around the world grapple with the COVID-19 pandemic.
Mar. 26, 2020—REDCap, a software application created and developed at Vanderbilt University Medical Center, has found widespread use in the public health response to the COVID-19 pandemic.